New hope for tough lung cancers: targeted pill shows promise in early trial
NCT ID NCT04010357
First seen Jan 11, 2026 · Last updated May 05, 2026 · Updated 23 times
Summary
This study tests a pill called abemaciclib in people with specific lung cancers (small cell, large cell neuroendocrine, and related types) that have stopped responding to chemotherapy. The goal is to see if the drug can shrink tumors and how safe it is. 14 participants will receive the drug, and researchers will track tumor response and survival.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for SMALL CELL LUNG CANCER are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Case Medical Center, University Hospitals Seidman Cancer Center, Case Comprehensive Cancer Center
Cleveland, Ohio, 44106-5065, United States
Conditions
Explore the condition pages connected to this study.